Tag : Pharmaceutical Contract Development

Aterian-Investment-Partners-to-Recapitalize-CPL,-a-Leading-Pharmaceutical-Contract-Development-and-Manufacturing-Organization (1)
Finance Fintech News

Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization

Business Wire
The proposed recapitalization is subject to the approval of the Ontario Superior Court of Justice in CPL’s and its affiliates’ proceedings pending under the Companies’ Creditors Arrangement Act. Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has entered into an agreement......
1